Head OfficeNovartis International AGCH-4002 BaselSwitzerland
+41 61 324 11 11+41 61 324 80 01Monday - Friday,8:30 - 17:00, GMT+1(Central European Time)
More information
Novartis International AGInvestor RelationsP.O. BoxCH-4002 BaselSwitzerland
+41 61 324 79 44investor.relations@novartis.com
Global Media RelationsEric AlthoffBasel, Switzerland
+41 61 324 7999eric.althoff@novartis.com
Find out more about the direct purchase of Novartis registered shares (for investors living in Switzerland, France, Liechtenstein and the UK). »
Find information for holders of Novartis American Depository Shares and about our ADS purchase plan. »
View specific information for Japanese investors, including translations of presentations. »
Find information about our Annual General Meeting on February 23, 2012. »
Find information about the current Novartis share buy-back program. »
Alcon information center
Pharmaceutical products
Clinical pipeline
Management bios
December 13 oncology call presentation (1.9 MB)
Form 20-F 2011 (2.0 MB)
Corporate organizational structure (41 KB)
Stock performance
Novartis announced its results for the first quarter of 2012 on April 24 »